Emerging Therapeutic Segments in the European Biopharmaceutical Markets

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

The research services provides an analysis of the European markets for emerging therapeutic areas such as antisense therapy, gene therapy and cell therapy. The research services segments the market based on the drug classes. The research analyses the challenges faced by the biopharmaceutical industry and the potential uses for the emerging therapeutic areas. The research also provides market sizes for the total biopharmaceutical markets and the market for emerging therapeutic areas.

Table of Contents

Emerging Therapeutic Segments in the European Biopharmaceutical Markets, Executive SummaryIntroductionSummaryEmerging Therapeutic Segments in the European Biopharmaceutical Markets, Market OverviewEmerging Therapeutic Segments in the European Biopharmaceutical Markets, Market AnalysisMarket IntroductionIntroductionMarket Engineering MeasurementsMain Classes of BiopharmaceuticalsRecent Product Approvals in EuropeCompetitive StructureResearch Scope and MethodologyScope and SegmentationResearch MethodologyMarket TrendsIndustry ChallengesMarket DriversMarket RestraintsPipeline AnalysisAntisense TherapiesGene TherapiesCell TherapiesEmerging Therapeutic Segments in the European Biopharmaceutical Markets, Revenue AnalysisTotal Market ForecastsRevenue ForecastsSegment AnalysisSegment ForecastsAntisense TherapiesGene TherapiesCell TherapiesEmerging Therapeutic Segments in the European Biopharmaceutical Markets, Decision Support DatabasesDatabasesCancer CasesPrevalence of ArthritisPrevalence of Multiple SclerosisPrevalence of Cardiovascular DiseasesPharma Government Biotech R&D Investment




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.